위원회 위원명단 - 대한내과학회

References
1. Meine TJ, Roe MT, Chen AY, et al. Association of intravenous morphine use and
outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement
Initiative. Am Heart J 2005;149:1043-9.
2. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic
review of the observational studies of selective and nonselective inhibitors
of cyclooxygenase 2. JAMA 2006;296:1633-44.
3. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of
nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement
from the American Heart Association. Circulation 2007;115:1634-42.
4. Pfisterer M, Cox JL, Granger CB, et al. Atenolol use and clinical outcomes after
thrombolysis for acute myocardial infarction: the GUSTO-I experience. Journal of
the American College of Cardiology 1998;32:634-40.
5. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta Blockade after myocardial
infarction: systematic review and meta regression analysis. BMJ 1999;318:
1730-7.
6. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management
of patients with ST-elevation myocardial infarction; a report of the American
College of Cardiology/American Heart Association Task Force on Practice
Guidelines (Committee to Revise the 1999 Guidelines for the Management of
patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:E1-211.
7. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in
45,852 patients with acute myocardial infarction: randomised placebo-controlled
trial. Lancet 2005;366:1622-32.
8. Lopez-Sendon J, Swedberg K, McMurray J, et al. Expert consensus document on
beta-adrenergic receptor blockers. Eur Heart J 2004;25:1341-62.
9. Jacobs AK, Antman EM, Faxon DP, Gregory T, Solis P. Development of systems
of care for ST-elevation myocardial infarction patients: executive summary. Circulation
2007;116:217-30.
10. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty
versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.
Circulation 2003;108:1809-14.
11. Garvey JL, MacLeod BA, Sopko G, Hand MM. Pre-hospital 12-lead electrocardiography
programs: a call for implementation by emergency medical services
systems providing advanced life support--National Heart Attack Alert Program
(NHAAP) Coordinating Committee; National Heart, Lung, and Blood Institute
(NHLBI); National Institutes of Health. J Am Coll Cardiol 2006;47:485-91.
12. Sim DS, Jeong MH, Ahn Y, et al. Safety and benefit of early elective percutaneous
coronary intervention after successful thrombolytic therapy for acute myocardial
infarction. Am J Cardiol 2009;103:1333-8.
13. Yusuf S, Mehta SR, Xie C, et al. Effects of reviparin, a low-molecular-weight heparin,
on mortality, reinfarction, and strokes in patients with acute myocardial infarction
presenting with ST-segment elevation. JAMA 2005;293:427-35.
14. Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and
reinfarction in patients with acute ST-segment elevation myocardial infarction: the
OASIS-6 randomized trial. JAMA 2006;295:1519-30.
급성 관동맥 증후군의 개정판
103